Ex Parte McElroy et al - Page 3




         Appeal No. 2003-0936                                                       
         Application No. 09/532,806                                                 


                   3536 contiguous nucleotides of the nucleic acid                  
                   sequence of SEQ ID NO:1.                                         
              10.  The isolated nucleic acid of claim 1, wherein said               
                   GRP promoter comprises from about 1500 to about                  
                   3536 contiguous nucleotides of the nucleic acid                  
                   sequence of SEQ ID NO:1.                                         
              11.  The isolated nucleic acid of claim 1, wherein said               
                   GRP promoter comprises from about 2000 to about                  
                   3536 contiguous nucleotides of the nucleic acid                  
                   sequence of SEQ ID NO:1.                                         
              12.  The isolated nucleic acid of claim 1, wherein said               
                   GRP promoter comprises from about 2500 to about                  
                   3536 contiguous nucleotides of the nucleic acid                  
                   sequence of SEQ ID NO:1.                                         
              13.  The isolated nucleic acid of claim 1, wherein said               
                   GRP promoter comprises from about 3000 to about                  
                   3536 contiguous nucleotides of the nucleic acid                  
                   sequence of SEQ ID NO:1.                                         
              14.  The isolated nucleic acid of claim 1, wherein said               
                   GRP promoter comprises the nucleic acid sequence of              
                   SEQ ID NO:1.                                                     
              15.  The isolated nucleic acid of claim 1, further                    
                   comprising an enhancer.                                          
              16.  The isolated nucleic acid of claim 15, wherein said              
                   enhancer comprises an intron.                                    
              17.  The isolated nucleic acid of claim 15, wherein said              
                   intron is selected from the group consisting of the              
                   rice actin 1 intron and the rice actin 2 intron.                 
              18.  The isolated nucleic acid of claim 1, further                    
                   comprising a terminator.                                         
              19.  The isolated nucleic acid of claim 18, wherein said              
                   terminator comprises an rbcS terminator.                         


                                         3                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007